Crawford & vs Ehealth
Crawford & is the larger business, with $1.31bn of revenue in fiscal 2025 against $554m for Ehealth (2.4 times as much). Ehealth grew faster (4.1% against -2.2%). Ehealth kept more of each dollar of sales as profit: a net margin of 7.2% against 1.5%.
| Latest fiscal year | Crawford &CRD.A, 2025 | EhealthEHTH, 2025 |
|---|---|---|
| Revenue | $1.31bn | $554m |
| Revenue growth | -2.2% | 4.1% |
| Net income | $19.6m | $40.0m |
| Operating margin | — | 12.0% |
| Net margin | 1.5% | 7.2% |
| Return on equity | 11.9% | 6.8% |
| Free cash flow | $94.8m | −$27.6m |
| Cash | $64.1m | $73.7m |
| Total debt | $228m | $113m |
| Debt to equity | — | 19.1% |
| Dividend per share | — | — |
| Dividend yield | 2.5% | — |
| Share buybacks | $10.5m | — |
| Employees | 9,943 | — |
| Market value | $546m | $17.7m |
| Price vs our value range | — | — |
| Moat score | — | 48 (Moderate) |
| Insider trades, 12 months | 0 buys, 18 sales | 2 buys, 4 sales |